DiscoverTalking Urology PodcastANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca
ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

Update: 2019-09-25
Share

Description

In this ANZUP conference highlight, Andrew Weickhardt chats with Betsy Plimack, Chief of the Division of Genitourinary Medical Oncology, Fox Chase Cancer Centre in the US. She talks about the future potential role of genetic mutations in urothelial cancer: can they predict response to treatments or even decide which treatments you should use? They also discuss the use of the new immuno-oncology agents in metastatic kidney cancer: what are the second line options, and how do we measure success of treatments- keep a close ear out for the emerging concept of treatment free survival as the yard stick for the immune-oncology agents.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

ANZUP 2019 Interviews - Andrew Weickhardt chats with Betsy Plimack, genetic mutations in bladder ca

Talking Urology